Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Allergin Globuli
- Development stage
- Unknown
- Lead developer
- MCM Klosterfrau
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Buccal, Oral, Sublingual
01
Overview
Allergin Globuli (also known as Klosterfrau Allergin Globuli) is a homeopathic pharmaceutical product developed by MCM Klosterfrau for the treatment and relief of hay fever (allergic rhinitis) symptoms, such as watery/itchy eyes, runny nose, sneezing, and respiratory mucosal irritation. The active ingredient is a homeopathic dilution of *Adhatoda vasica* (Indian lungwort) at the D2 potency (Adhatoda vasica Dil. D2). *Adhatoda vasica* has a long history of use in traditional Ayurvedic medicine for respiratory ailments. Its primary bioactive quinazoline alkaloids, such as vasicine and vasicinone, are believed to contribute to its bronchodilatory, anti-inflammatory, and antiallergic properties, potentially by modulating histamine H1 and acetylcholine receptors to prevent bronchoconstriction and reduce allergic airway responses.
- Brand names
- Allergin GlobuliKlosterfrau Allergin Globuli
- Other names
- Adhatoda vasica D2Adhatoda vasica Dil. D2Justicia adhatoda Dil. D2
02
Targets
HRH1 (Histamine H1 Receptor)mAChR (Muscarinic acetylcholine receptors)
Beyond the preview
Go deeper on Allergin Globuli.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Allergin Globuli.